Matches in Data.gov.be for { <http://data.gov.be/.well-known/genid/97c111a523604f4dac6684a233a43a172-b1012> ?p ?o ?g. }
Showing items 1 to 84 of
84
with 100 items per page.
- 97c111a523604f4dac6684a233a43a172-b1012 accessRights PUBLIC @default.
- 97c111a523604f4dac6684a233a43a172-b1012 description "Die Substitutionsbehandlung von Opiaten ist eine medizinische Behandlung für Patienten, die auf Opiate angewiesen sind. Die in diesem Zusammenhang verwendeten Medikamente enthalten Methadon oder Buprenorphin, die starke Morphinomimetika sind. Sie sind wirksam bei der Behandlung der Abhängigkeit von Opiaten, einschließlich der Verringerung des Abstinenzsyndroms. Sie werden als Betäubungsmittel und psychotrope Substanzen eingestuft. Ihre Verschreibung und Lieferung sind streng reguliert. Diese Medikamente erfordern besondere Vorsichtsmaßnahmen für die Anwendung und eine sehr strenge Überwachung der Patienten." @default.
- 97c111a523604f4dac6684a233a43a172-b1012 description "Le traitement de substitution des opiacés est un traitement médicamenteux pour les patients dépendants des opiacés. Les médicaments utilisés dans ce contexte contiennent de la méthadone ou de la buprénorphine, qui sont de puissants morphinomimétiques. Ils sont efficaces dans le traitement de la dépendance aux opiacés, y compris la réduction du syndrome d'abstinence. Ils sont classés comme stupéfiants et substances psychotropes. Leur prescription et leur livraison sont strictement réglementées. Ces médicaments nécessitent des précautions particulières d'utilisation et une surveillance très stricte des patients." @default.
- 97c111a523604f4dac6684a233a43a172-b1012 description "Substitutiebehandeling voor opiaten is een medicinale behandeling voor patiënten die afhankelijk zijn van opiaten. De geneesmiddelen die in deze context worden gebruikt, bevatten methadon of buprenorfine, krachtige morfinomimetica. Ze zijn effectief bij de behandeling van de afhankelijkheid van opiaten, waaronder het verminderen van het onthoudingssyndroom. Ze worden geclassificeerd als verdovende middelen en psychotrope stoffen. Hun recept en levering zijn strikt gereguleerd. Deze geneesmiddelen vereisen speciale voorzorgsmaatregelen voor gebruik en een zeer strikte controle van patiënten." @default.
- 97c111a523604f4dac6684a233a43a172-b1012 description "Substitution treatment for opiates is a medicinal treatment for patients dependent on opiates. The drugs used in this context contain methadone or buprenorphine, which are powerful morphinomimetics. They are effective in the treatment of the dependence on opiates, including reducing the abstinence syndrome. They are classified as narcotic drugs and psychotropic substances. Their prescription and delivery are strictly regulated. These drugs require special precautions for use and a very strict monitoring of patients." @default.
- 97c111a523604f4dac6684a233a43a172-b1012 identifier "14e7d4b7-3fc2-47a1-8cdf-3b5fd0aacaa7" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 language ENG @default.
- 97c111a523604f4dac6684a233a43a172-b1012 modified "2021-04-02" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 publisher 0884579424 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 spatial 2802361 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 title "Behandlung der Ersetzung des belgischen Registers" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 title "Belgian Registry Substitution Treatment" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 title "Substitutiebehandeling van het Belgisch register" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 title "Traitement de substitution au registre belge" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 type Dataset @default.
- 97c111a523604f4dac6684a233a43a172-b1012 contactPoint genid107451 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 contactPoint genid107452 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 distribution 97c111a523604f4dac6684a233a43a172-b1015 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 distribution 97c111a523604f4dac6684a233a43a172-b1016 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC N02AC52" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC N02AE01" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC N07BC01" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC N07BC02" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC QN02AC90" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ATC-L1 N" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Agence fédérale des médicaments et des produits de santé (AFMPS)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Belgique (country)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Belgium (country)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "België (country)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "CAS 52485-79-7" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "CAS 76-99-3" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChEBI 3216" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChEBI 6807" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChEMBL 511142" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChEMBL 651" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChemSpider 3953" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ChemSpider 559124" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Comité de sécurité de l'information: chambre sécurité sociale et santé" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Dolophine" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "DrugBank DB00333" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "DrugBank DB00921" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ECHA 100.000.907" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ECHA 100.052.664" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "European Monitoring Centre for Drugs and Drug Addiction (EMCDDA)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Europees waarnemingscentrum voor drugs en drugsverslaving (EMCDDA)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Europäische Beobachtungsstelle für Drogen und Drogensucht (EMCDDA)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "FarmaFlux vzw/asbl" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Federaal Agentschap voor Geneesmiddelen en Gezondheidsproducten (FAGG)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Federal Agency for Medicines and Health Products (FAMHP)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Föderalagentur für Arzneimittel und Gesundheitsprodukte (FAGP)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "HDBP0047" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Healthdata.be (Sciensano)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "ICD10 F00–F99" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "IUPHAR 1670" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "IUPHAR 5458" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Informatieveiligheidscomité: kamer sociale zekerheid en gezondheid" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "KEGG D07132" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "KEGG D08195" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "MeSH D002047" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "MeSH D008691" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "MedlinePlus a605002" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "MedlinePlus a682134" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Methadose" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Observatoire européen des drogues et des toxicomanies (EMCDDA)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "PubChem 4095" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "PubChem 644073" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Réseau Européen d'Information sur les Drogues et les Toxicomanies (REITOX)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "SNOMED CT 387173000" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "SNOMED CT 387286002" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Sixmo" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "Subutex" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "UNII 40D3SCR4GZ" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "UNII UC6VBE7V1Z" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "buprenorfine" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "buprenorphine" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "buprénorphine" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "methadon" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "methadone" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "méthadone" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "project in preparation" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "source data at healthdata.be (Sciensano)" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 keyword "substitution treatment" @default.
- 97c111a523604f4dac6684a233a43a172-b1012 landingPage 14e7d4b7-3fc2-47a1-8cdf-3b5fd0aacaa7 @default.
- 97c111a523604f4dac6684a233a43a172-b1012 theme HEAL @default.